CDMO AcuraBio has selected Cytiva’s two-step purification system, AKTA readyflux, to provide a plasmid DNA (pDNA) service to its customers. According to Australia-based contract development manufacturing organization (CDMO) AcuraBio, the offering of pDNA services to its customers aims to ease supply chain constraints for messenger RNA (mRNA) and cell and gene therapies (CGTs). “The demand for pDNA manufacture to support the clinical development of advanced therapies has never been greater. Demand has been fueled by the growth in vaccines and…